Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Paul L. Berns currently holds 15,042,035 shares of ALLOS THERAPEUTICS INC (ALTH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul L. Berns has been a net seller of ALTH stock. They have purchased $20.3M and sold $25.0M worth of shares.
Paul L. Berns's most recent insider trade was on Jun 22, 2026, when they purchased 1,250,000 shares at $16.00 per share.
Paul L. Berns serves as Executive at ALLOS THERAPEUTICS INC (ALTH). They have executed 139 insider transactions totaling $45.3M over their tenure at the company.
Paul L. Berns holds the position of Executive at ALLOS THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Paul L. Berns has shown a selling trading pattern, with $20.3M in total purchases and $25.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Paul L. Berns was on Jun 24, 2016, when they sold $23.0M worth of ANAC shares. This transaction involved 231,311 shares at $99.25 per share.
Paul L. Berns currently owns 15,042,035 shares of ALLOS THERAPEUTICS INC (ALTH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Paul L. Berns's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Paul L. Berns has 139 Form 4 filings on record as an insider at ALLOS THERAPEUTICS INC.
Set alerts for Paul L. Berns and 40,000+ other insiders.